Ovarian Cancer -$0.22 EPS Expected for ImmunoGen, Inc. (NASDAQ:IMGN) This QuarterBy adminJune 5, 20220 Equities research analysts predict that ImmunoGen, Inc. (NASDAQ:IMGN – Get Rating) will report ($0.22) earnings per share (EPS) for the…
Endometrial Cancer HUTCHMED (China) Limited (NASDAQ:HCM) Receives Average Recommendation of “Hold” from BrokeragesBy adminMay 30, 20220 Shares of HUTCHMED (China) Limited (NASDAQ:HCM – Get Rating) have been given a consensus recommendation of “Hold” by the six…
